Medial temporal atrophy in early and late-onset alzheimer's disease

Neurobiology of Aging

Volumn 35, Issue 9, 2014, Pages 2004-2012

  Cavedo, Enrica ^a,b   Pievani, Michela ^a   Boccardi, Marina ^a   Galluzzi, Samantha ^a   Bocchetta, Martina ^a,c   Bonetti, Matteo ^d   Thompson, Paul M ^e,f   Frisoni, Giovanni B ^a,g  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Istituto Clinico Citta di Brescia   (Italy)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

AD; Age at onset; Amygdala; Hippocampus; Morphology; MRI

Indexed keywords

ADULT; AGE DISTRIBUTION; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BASOLATERAL AMYGDALA; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL AMYGDALA; FEMALE; GENE FREQUENCY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LEFT HEMISPHERE; MALE; PRIORITY JOURNAL; RIGHT HEMISPHERE; AGED; ATROPHY; LIMBIC SYSTEM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; ORGAN SIZE; PATHOLOGY; PSYCHOLOGY; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYGDALA; ATROPHY; FEMALE; HIPPOCAMPUS; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE;

EID: 84902104048     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.03.009     Document Type: Article

References (73)

1. Adolphs R., Tranel D., Denburg N. Impaired emotional declarative memory following unilateral amygdala damage. Learn. Mem. 2000, 7:180-186.
2. Amodio P., Wenin H., Del Piccolo F., Mapelli D., Montagnese S., Pellegrini A., Musto C., Gatta A., Umilta C. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin. Exp. Res 2002, 14:117-131.
3. Arriagada P.V., Marzloff K., Hyman B.T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992, 42:1681-1688.
4. Bali J., Gheinani A.H., Zurbriggen S., Rajendran L. Role of genes linked to sporadic Alzheimer's disease risk in the production of beta-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A 2012, 109:15307-15311.
5. Barnes J., Whitwell J.L., Frost C., Josephs K.A., Rossor M., Fox N.C. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch. Neurol. 2006, 63:1434-1439.
6. Basso M., Yang J., Warren L., MacAvoy M.G., Varma P., Bronen R.A., van Dyck C.H. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry Res. 2006, 146:251-261.
7. Blacker D., Tanzi R.E. The genetics of Alzheimer disease: current status and future prospects. Arch. Neurol. 1998, 55:294-296.
8. Buchanan T.W., Tranel D., Adolphs R. Memories for emotional autobiographical events following unilateral damage to medial temporal lobe. Brain 2006, 129:115-127.
9. Buchanan T.W., Tranel D., Adolphs R. Aspecific role for the human amygdala in olfactory memory. Learn. Mem. 2003, 10:319-325.
10. Caffarra P., Vezzadini G., Dieci F., Zonato F., Venneri A. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol. Sci. 2002, 22:443-447.
11. Carlesimo G.A., Marfia G.A., Loasses A., Caltagirone C. Perceptual and conceptual components in implicit and explicit stem completion. Neuropsychologia 1996, 34:785-792.
12. Catani M., Acqua F.D., de Schotten M.T. Arevised limbic system model for memory, emotion and behaviour. Neurosci. Biobehav. Rev 2013, 37:1724-1737.
13. Cavedo E., Boccardi M., Ganzola R., Canu E., Beltramello A., Caltagirone C., Thompson P.M., Frisoni G.B. Local structural differences in the amygdala of Alzheimer's patients on 3 Tesla MRI. Neurology 2011, 76:727-733.
14. Cho H., Seo S.W., Kim J.H., Kim C., Ye B.S., Kim G.H., Noh Y., Kim H.J., Yoon C.W., Seong J.K., Kim C.H., Kang S.J., Chin J., Kim S.T., Lee K.H., Na D.L. Changes in subcortical structures in early- versus late-onset Alzheimer's disease. Neurobiol. Aging 2013, 34:1740-1747.
15. Cho H., Seo S.W., Kim J.H., Suh M.K., Lee J.H., Choe Y.S., Lee K.H., Kim J.S., Kim G.H., Noh Y., Ye B.S., Kim H.J., Yoon C.W., Chin J., Na D.L. Amyloid deposition in early onset versus late onset Alzheimer's disease. J.Alzheimers Dis 2013, 35:813-821.
16. Cuenod C.A., Denys A., Michot J.L., Jehenson P., Forette F., Kaplan D., Syrota A., Boller F. Amygdala atrophy in Alzheimer's disease. An invivo magnetic resonance imaging study. Arch. Neurol. 1993, 50:941-945.
17. De Renzi E., Vignolo L.A. The token test: a sensitive test to detect receptive disturbances in aphasics. Brain 1962, 85:665-678.
18. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
19. Frisoni G.B., Beltramello A., Weiss C., Geroldi C., Bianchetti A., Trabucchi M. Linear measures of atrophy in mild Alzheimer disease. AJNR Am. J. Neuroradiol. 1996, 17:913-923.
20. Frisoni G.B., Galluzzi S., Pantoni L., Filippi M. The effect of white matter lesions on cognition in the elderly-small but detectable. Nat. Clin. Pract. Neurol. 2007, 3:620-627.
21. Frisoni G.B., Pievani M., Testa C., Sabattoli F., Bresciani L., Bonetti M., Beltramello A., Hayashi K.M., Toga A.W., Thompson P.M. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007, 130:720-730.
22. Frisoni G.B., Testa C., Sabattoli F., Beltramello A., Soininen H., Laakso M.P. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J.Neurol. Neurosurg. Psychiatry 2005, 76:112-114.
23. Galluzzi S., Testa C., Boccardi M., Bresciani L., Benussi L., Ghidoni R., Beltramello A., Bonetti M., Bono G., Falini A., Magnani G., Minonzio G., Piovan E., Binetti G., Frisoni G.B. The Italian brain normative archive of structural MR scans: norms for medial temporal atrophy and white matter lesions. Aging Clin. Exp. Res. 2009, 21:266-276.
24. Gomez-Isla T., Growdon W.B., McNamara M.J., Nochlin D., Bird T.D., Arango J.C., Lopera F., Kosik K.S., Lantos P.L., Cairns N.J., Hyman B.T. The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain 1999, 122(Pt 9):1709-1719.
25. Herzog A.G., Kemper T.L. Amygdaloid changes in aging and dementia. Arch. Neurol. 1980, 37:625-629.
26. Heun R., Mazanek M., Atzor K.R., Tintera J., Gawehn J., Burkart M., Gansicke M., Falkai P., Stoeter P. Amygdala-hippocampal atrophy and memory performance in dementia of Alzheimer type. Dement. Geriatr. Cogn. Disord. 1997, 8:329-336.
27. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J.Lipid Res. 1990, 31:545-548.
28. Ho G.J., Hansen L.A., Alford M.F., Foster K., Salmon D.P., Galasko D., Thal L.J., Masliah E. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport 2002, 13:1825-1828.
29. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. Anew clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
30. Ishii K., Kawachi T., Sasaki H., Kono A.K., Fukuda T., Kojima Y., Mori E. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am. J. Neuroradiol. 2005, 26:333-340.
31. Jacobs D., Sano M., Marder K., Bell K., Bylsma F., Lafleche G., Albert M., Brandt J., Stern Y. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 1994, 44:1215-1220.
32. Karas G., Scheltens P., Rombouts S., van Schijndel R., Klein M., Jones B., van der Flier W., Vrenken H., Barkhof F. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 2007, 49:967-976.
33. Koedam E.L., Lauffer V., van der Vlies A.E., van der Flier W.M., Scheltens P., Pijnenburg Y.A. Early-versus late-onset Alzheimer's disease: more than age alone. J.Alzheimers Dis. 2010, 19:1401-1408.
34. Kono K., Kuzuya F., Yamamoto T., Endo H. Comparative study of cerebral ventricular dilation and cognitive function in patients with Alzheimer's disease of early versus late onset. J.Geriatr. Psychiatry Neurol. 1994, 7:39-45.
35. Koss E., Edland S., Fillenbaum G., Mohs R., Clark C., Galasko D., Morris J.C. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: a CERAD analysis, part XII. Neurology 1996, 46:136-141.
36. Krasuski J.S., Alexander G.E., Horwitz B., Daly E.M., Murphy D.G., Rapoport S.I., Schapiro M.B. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol. Psychiatry 1998, 43:60-68.
37. LeDoux J. The amygdala. Curr. Biol. 2007, 17:R868-R874.
38. Mai J.K., Assheuer J., Paxinos G. Atlas of the Human Brain 1997, Accademy Press, San Diego.
39. Martinez-Castillo E., Arrazola J., Fernandez A., Maestu F., Ortiz T. Atrophy of the amygdala complex and neuropsychiatric expression of Alzheimer's disease. Rev. Neurol. 2001, 33:477-482.
40. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
41. Meyer M.R., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., Steffens D.C., Wyse B.W., Breitner J.C. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nat. Genet. 1998, 19:321-322.
42. Moller C., Vrenken H., Jiskoot L., Versteeg A., Barkhof F., Scheltens P., van der Flier W.M. Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease. Neurobiol. Aging 2013, 34:2014-2022.
43. Novelli G., Papagno C., Capitani E., Laiacona M., Vallar G., Cappa S.F. Tre testclinici di ricerca e produzione lessicale. Taratura su soggetti normali 1986, 47:477-506.
44. Pievani M., Bocchetta M., Boccardi M., Cavedo E., Bonetti M., Thompson P.M., Frisoni G.B. Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study. Neurobiol. Aging 2013, 34:1728-1739.
45. Pikkarainen M., Ronkko S., Savander V., Insausti R., Pitkanen A. Projections from the lateral, basal, and accessory basal nuclei of the amygdala to the hippocampal formation in rat. J.Comp. Neurol. 1999, 403:229-260.
46. Prestia A., Boccardi M., Galluzzi S., Cavedo E., Adorni A., Soricelli A., Bonetti M., Geroldi C., Giannakopoulos P., Thompson P., Frisoni G. Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia. Psychiatry Res. 2011, 192:77-83.
47. Price J.L. Comparative aspects of amygdala connectivity. Ann. N.Y. Acad. Sci. 2003, 985:50-58.
48. Pruessner J.C., Li L.M., Serles W., Pruessner M., Collins D.L., Kabani N., Lupien S., Evans A.C. Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb. Cortex 2000, 10:433-442.
49. Qiu A., Fennema-Notestine C., Dale A.M., Miller M.I. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. Neuroimage 2009, 45:656-661. Alzheimer's Disease Neuroimaging Initiative.
50. Raux G., Guyant-Marechal L., Martin C., Bou J., Penet C., Brice A., Hannequin D., Frebourg T., Campion D. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J.Med. Genet. 2005, 42:793-795.
51. Reid W., Broe G., Creasey H., Grayson D., McCusker E., Bennett H., Longley W., Sulway M.R. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population. Arch. Neurol. 1996, 53:1056-1061.
52. Rovelet-Lecrux A., Hannequin D., Raux G., Le Meur N., Laquerriere A., Vital A., Dumanchin C., Feuillette S., Brice A., Vercelletto M., Dubas F., Frebourg T., Campion D. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet. 2006, 38:24-26.
53. Sa F., Pinto P., Cunha C., Lemos R., Letra L., Simoes M., Santana I. Differences between early and late-onset Alzheimer's disease in neuropsychological tests. Front. Neurol. 2012, 3:81.
54. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol. Rev. 2003, 83:803-834.
55. Schafe G.E., Doyere V., LeDoux J.E. Tracking the fear engram: the lateral amygdala is an essential locus of fear memory storage. J.Neurosci. 2005, 25:10010-10014.
56. Scott S.A., DeKosky S.T., Scheff S.W. Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction. Neurology 1991, 41:351-356.
57. Selden N.R., Gitelman D.R., Salamon-Murayama N., Parrish T.B., Mesulam M.M. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998, 121(Pt 12):2249-2257.
58. Shiino A., Watanabe T., Kitagawa T., Kotani E., Takahashi J., Morikawa S., Akiguchi I. Different atrophic patterns in early- and late-onset Alzheimer's disease and evaluation of clinical utility of a method of regional z-score analysis using voxel-based morphometry. Dement. Geriatr. Cogn. Disord. 2008, 26:175-186.
59. Shiino A., Watanabe T., Maeda K., Kotani E., Akiguchi I., Matsuda M. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 2006, 33:17-26.
60. Sjogren M., Vanderstichele H., Agren H., Zachrisson O., Edsbagge M., Wikkelso C., Skoog I., Wallin A., Wahlund L.O., Marcusson J., Nagga K., Andreasen N., Davidsson P., Vanmechelen E., Blennow K. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin. Chem. 2001, 47:1776-1781.
61. Smits L.L., Pijnenburg Y.A., Koedam E.L., van der Vlies A.E., Reuling I.E., Koene T., Teunissen C.E., Scheltens P., van der Flier W.M. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J.Alzheimers Dis. 2012, 30:101-108.
62. Spinnler H., Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Italian Journal of Neurological Sciences 1987, 8:1-20.
63. Stefanacci L., Amaral D.G. Topographic organization of cortical inputs to the lateral nucleus of the macaque monkey amygdala: a retrograde tracing study. J.Comp. Neurol. 2000, 421:52-79.
64. Suribhatla S., Baillon S., Dennis M., Marudkar M., Muhammad S., Munro D., Spreadbury C., Lindesay J. Neuropsychological performance in early and late onset Alzheimer's disease: comparisons in a memory clinic population. Int. J. Geriatr. Psychiatry 2004, 19:1140-1147.
65. Thompson P.M., Hayashi K.M., De Zubicaray G.I., Janke A.L., Rose S.E., Semple J., Hong M.S., Herman D.H., Gravano D., Doddrell D.M., Toga A.W. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 2004, 22:1754-1766.
66. Thompson P.M., MacDonald D., Mega M.S., Holmes C.J., Evans A.C., Toga A.W. Detection and mapping of abnormal brain structure with a probabilistic atlas of cortical surfaces. J.Comput. Assist. Tomogr. 1997, 21:567-581.
67. Tsuchiya K., Kosaka K. Neuropathological study of the amygdala in presenile Alzheimer's disease. J.Neurol. Sci. 1990, 100:165-173.
68. van de Pol L.A., Hensel A., Barkhof F., Gertz H.J., Scheltens P., van der Flier W.M. Hippocampal atrophy in Alzheimer disease: age matters. Neurology 2006, 66:236-238.
69. van der Flier W.M., Pijnenburg Y.A., Fox N.C., Scheltens P. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ε4 allele. Lancet Neurol. 2011, 10:280-288.
70. van der Vlies A.E., Staekenborg S.S., Admiraal-Behloul F., Prins N.D., Barkhof F., Vrenken H., Reiber J.H., Scheltens P., van der Flier W.M. Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset Alzheimer's disease. J.Alzheimers Dis. 2013, 35:169-178.
71. Wahlund L.O., Barkhof F., Fazekas F., Bronge L., Augustin M., Sjogren M., Wallin A., Ader H., Leys D., Pantoni L., Pasquier F., Erkinjuntti T., Scheltens P. Anew rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001, 32:1318-1322. European Task Force on Age-Related White Matter Changes.
72. Whitwell J.L., Dickson D.W., Murray M.E., Weigand S.D., Tosakulwong N., Senjem M.L., Knopman D.S., Boeve B.F., Parisi J.E., Petersen R.C., Jack C.R., Josephs K.A. Neuroimaging correlates of pathologically defined subtypesof Alzheimer's disease: a case-control study. Lancet Neurol. 2012, 11:868-877.
73. Wolk D.A., Dickerson B.C. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A 2010, 107:10256-10261. Alzheimer's Disease Neuroimaging Initiative.